📄 medicine

Peripheral Thermoregulatory Compensation During Acute Heat Exposure in Heat-Vulnerable Adults: Physiological Responses Consistent with Non-Adrenergic, Non-Cholinergic Pathway Involvement

This pilot study demonstrates that pharmacological inhibition of prostaglandin and histamine pathways significantly impairs peripheral thermoregulatory responses, such as sweating and skin temperature regulation, during acute heat exposure in heat-vulnerable adults, suggesting these non-adrenergic, non-cholinergic mediators play a contributory role in human heat dissipation.

Original authors: Emmanuel kairania, Onesimas Ainembabazi, Ronald Tweheyo

Published 2026-08-04

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Emmanuel kairania, Onesimas Ainembabazi, Ronald Tweheyo

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine your body is a high-performance car engine. When you're idling, it runs cool, but when you hit the gas—say, by running a marathon or working in a scorching sun—it generates massive amounts of heat. If that heat isn't dumped quickly, the engine overheats, and things start to melt. To prevent this, your body has a built-in cooling system. Think of it like a dual-fan setup: one fan blows air over the radiator (your skin blood flow), and the other sprays water to evaporate and cool things down (sweating). For a long time, scientists thought this cooling system was run entirely by two specific types of "wiring" in your nervous system: the adrenergic and cholinergic pathways. You can think of these as the main electrical cables connecting the brain to the cooling fans.

But recently, scientists have started wondering if there are other, quieter wires in the mix. These are called "non-adrenergic, non-cholinergic" (or NANC) pathways. They aren't the main electrical cables; instead, they are more like chemical messengers—tiny signals sent by substances like prostaglandins and histamine—that might help fine-tune the cooling fans. We know these chemicals do other things in the body, like causing inflammation or allergic reactions, but do they also help you stay cool when the heat is on? As the world gets hotter and heatwaves become more common, figuring out exactly how our bodies cool down is crucial. If we can understand every part of the cooling system, we might be able to spot people who are at risk of overheating before they even feel sick.

This is where a small but clever study comes in. Researchers wanted to see if these "chemical messenger" pathways actually help us cool down when we are in a hot environment. To test this, they didn't just watch people sweat; they played a game of "what if" using medicine. They took six adults who are generally healthy but might be a bit more sensitive to heat (perhaps because they don't exercise much) and put them through three different scenarios in a hot room (35°C, which is about 95°F) while they walked on a treadmill.

In the first scenario, the "Control" run, the participants took nothing. In the second, they took ibuprofen (400 mg), a common painkiller that blocks the body's production of prostaglandins. In the third, they took cetirizine (10 mg), an antihistamine that blocks histamine. The idea was simple: if these chemicals are important for cooling, then blocking them should make the body's cooling system less efficient.

The results were fascinating. When the participants were in the hot room, their bodies naturally tried to cool down by increasing their skin temperature (letting heat out) and sweating. However, when the participants took ibuprofen to block prostaglandins, their sweating dropped significantly, and their skin didn't get as hot as it did in the control run. This suggests that without prostaglandins, the body's "water spray" (sweating) and "radiator" (skin blood flow) weren't working as hard. The antihistamine (cetirizine) also caused a drop in cooling, but it wasn't as dramatic as the ibuprofen.

Despite these changes, the participants' core body temperature (the temperature of their engine) stayed relatively stable in all three scenarios. This is a key finding: even though the cooling system was slightly hampered by the drugs, the body managed to keep the engine from overheating for the short time of the experiment. It seems the body has a lot of backup power.

The study suggests that prostaglandins and histamine do play a role in helping us cool down, acting as helpful assistants to the main nervous system wires. The effect was strongest on sweating, which the researchers measured as having a very large impact when these chemicals were blocked. However, the authors are careful to note that this is a "pilot study" with only six people. They aren't saying they have proven exactly how these chemicals work or that this is the whole story. Instead, they are saying, "Hey, the data suggests these chemical messengers are likely part of the team."

So, what does this mean for us? It doesn't mean you should stop taking ibuprofen before a run, but it does tell us that our body's cooling system is more complex than we thought. It's not just one or two wires; it's a whole network of signals working together. As climate change brings more extreme heat, understanding these hidden helpers could help doctors and safety experts figure out who might struggle to cool down and why. For now, this study is a small but exciting clue in the puzzle of how we survive the heat.

Technical Summary: Peripheral Thermoregulatory Compensation During Acute Heat Exposure in Heat-Vulnerable Adults

Problem Statement
Human thermoregulation during heat exposure relies on coordinated autonomic, vascular, and sudomotor responses to maintain thermal homeostasis. While sympathetic adrenergic and cholinergic pathways are established as the primary regulators of heat dissipation (cutaneous vasodilation and eccrine sweating), emerging evidence suggests that non-adrenergic, non-cholinergic (NANC) mediators, specifically prostaglandins and histamine, may also contribute to peripheral thermoregulatory control. However, the physiological contribution of these NANC pathways during acute heat stress in heat-vulnerable adults remains poorly characterized. As climate change increases the frequency of extreme heat events, understanding these mechanisms is critical for identifying early physiological markers of impaired heat dissipation and improving occupational heat-risk assessment.

Methodology
This study employed a repeated-measures, randomized crossover experimental design to investigate thermoregulatory responses under three distinct physiological conditions:

Control: No pharmacological intervention.
Prostaglandin Pathway Inhibition: Administration of ibuprofen (400 mg orally) 90 minutes prior to testing.
Histamine Pathway Inhibition: Administration of cetirizine (10 mg orally) 90 minutes prior to testing.

Participants: Six heat-vulnerable adults (four males, two females; aged 24–41 years) were recruited based on lifestyle characteristics associated with heat intolerance (sedentary behavior, reduced exercise tolerance).
Protocol: Participants underwent standardized heat exposure in an environmental chamber (35°C; 50–60% relative humidity) combined with moderate treadmill exercise. Each session included a 15-minute baseline, 30 minutes of exercise, and a 20-minute recovery period, with a minimum 72-hour washout between sessions.
Measurements: Continuous monitoring included core body temperature (tympanic), mean skin temperature (surface thermistors), heart rate, and blood pressure. Whole-body sweat rate was estimated via nude body mass changes corrected for fluid intake.
Analysis: Data were analyzed using repeated-measures ANOVA with Bonferroni-adjusted post hoc comparisons. Effect sizes were quantified using partial eta squared ( $\eta^2_p$ ).

Key Results

Thermal Responses: Heat exposure significantly increased skin temperature and sweat rate across all conditions ( $P < 0.01$ ).
Pharmacological Effects:
- Ibuprofen (Prostaglandin Inhibition): Produced the greatest attenuation of sweating. While participants receiving prostaglandin blockade exhibited the greatest increase in core temperature during exercise relative to other conditions, repeated-measures ANOVA demonstrated no statistically significant overall differences in core body temperature across experimental phases ( $P = 0.584$ ).
- Cetirizine (Histamine Inhibition): Resulted in a moderate impairment of peripheral heat dissipation, intermediate between the control and ibuprofen conditions.
Effect Sizes: Large physiological effect sizes were observed for sweat rate ( $\eta^2_p = 0.88$ ) and mean skin temperature ( $\eta^2_p = 0.70$ ). Core body temperature showed a modest effect size ( $\eta^2_p = 0.10$ ) and did not reach statistical significance across conditions, though the observed effect size suggested a modest physiological influence of pharmacological blockade on thermal regulation.
Compensation: Despite the attenuation of peripheral heat-loss mechanisms (sweating and skin temperature elevation) due to pharmacological modulation, core body temperature remained relatively stable, indicating that compensatory thermoregulatory mechanisms were effective in the short term.

Key Contributions
This pilot study provides preliminary physiological evidence that prostaglandin- and histamine-associated pathways contribute to peripheral thermoregulatory compensation during acute heat exposure. By using pharmacological probes (ibuprofen and cetirizine) to transiently attenuate these pathways, the study demonstrates that:

Inhibition of prostaglandin synthesis significantly reduces sweating efficiency and alters skin temperature responses.
Histamine pathway inhibition also impairs peripheral heat dissipation, though to a lesser degree than prostaglandin inhibition.
These findings support the hypothesis that NANC-related mechanisms complement classical autonomic pathways in facilitating human heat dissipation.

Significance and Claims
The authors claim that these findings offer preliminary evidence supporting a contributory role of NANC mechanisms in human heat dissipation. The study suggests that peripheral thermoeffector responses, particularly sweating efficiency and skin temperature regulation, may serve as sensitive physiological markers of early heat strain before clinically significant elevations in core body temperature occur.

The paper explicitly frames these findings as exploratory and hypothesis-generating. It does not claim to establish direct causal molecular mechanisms, noting that ibuprofen and cetirizine are broad pharmacological probes rather than selective inhibitors of all NANC signaling. The authors emphasize that direct assessment of cutaneous vascular function and molecular biomarkers (e.g., prostaglandins, histamine, nitric oxide) is required to confirm the mechanistic basis of these responses.

The significance of this work lies in its potential to inform future translational research. If validated in larger cohorts, these peripheral thermoeffector responses could contribute to:

Individualized heat-vulnerability screening.
Wearable physiological monitoring systems for early heat-risk detection.
Improved occupational heat-health guidelines and climate adaptation strategies for vulnerable populations.

The study concludes that while the observed patterns support the concept of NANC-associated signaling in thermoregulation, larger, adequately powered studies integrating physiological monitoring with biomarker profiling are warranted to validate these preliminary findings.

Technical Summary: Peripheral Thermoregulatory Compensation During Acute Heat Exposure in Heat-Vulnerable Adults

More like this